About Kopran Research Laboratories Limited
Data last updated: 15 December 2025
Kopran Research Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Kopran Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 12 August 1986, the company has been in operation for over 40 years.
Registered with ROC Mumbai under CIN U24230MH1986PLC040601.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹22.5 Cr. Formerly known as Kopran Formulations Private Limited and Kopran Formulations Limited. It is led by directors including Sunita Banerji and Rakesh Arunkumar Doshi.
Last AGM: 10 September 2024. Financial statements filed for year ended 31 March 2024. Office: 1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹365.89 Cr, a growth of 13% compared to the previous year.
The company has a workforce of approximately 538 employees as per the latest available data. It operates as a subsidiary of Kopran Limited.
The company is associated with 1 brand - Kopran. As per MCA filings, the company has open charges of ₹194 Cr and satisfied charges of ₹39.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kopran.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, India – 400018
-
IndustryPharma, Drug Formulation & Development, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Kopran Research Laboratories Limited
Kopran Research Laboratories Limited has undergone 2 name changes throughout its history. The company was previously known as Kopran Formulations Private Limited, and Kopran Formulations Limited. The current legal name is Kopran Research Laboratories Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Kopran Research Laboratories Limited | Current |
| Kopran Formulations Private Limited | Previous |
| Kopran Formulations Limited | Previous |
CIN History of Kopran Research Laboratories Limited
Kopran Research Laboratories Limited has one previous CIN (Corporate Identification Number): L24230MH1986PLC040601. The current CIN is U24230MH1986PLC040601, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1986PLC040601 | Current |
| L24230MH1986PLC040601 | Previous |
Associated Brands with Kopran Research Laboratories Limited
Kopran Research Laboratories Limited operates one associated brand: Kopran. These brands represent Kopran Research Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical Company manufacturing a range of products | kopran.com |
Competitors & Alternatives of Kopran Research Laboratories Limited
Brands and companies operating in the same space as Kopran Research Laboratories Limited include Concord Biotech, Almac Group, Indoco Remedies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Kopran Research Laboratories Limited
Kopran Research Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Kopran Research Laboratories Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Kopran Research Laboratories Limited
Kopran Research Laboratories Limited is audited by NGS & Co. LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NGS & Co. LLP | Locked | Locked | Locked |
Complete auditor history for Kopran Research Laboratories Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kopran Research Laboratories Limited
Kopran Research Laboratories Limited is currently managed by 5 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sunita Banerji
Also directs:
Shihan Enterprises Private Limited
|
Director | 01 Mar 2016 | 10 Years 4 Months | Current |
|
Rakesh Arunkumar Doshi
Also directs:
Duram Pharmachem Private Limited
|
Director | 14 Nov 2017 | 8 Years 8 Months | Current |
| Chandra Mohan Singhi | Whole-Time Director | 24 Jun 2015 | 11 Years 0 Months | Current |
| Vandana Surendra Somani | Director | 18 Feb 2015 | 11 Years 5 Months | Current |
| Mamta Ashok Biyani | Director | 14 Nov 2017 | 8 Years 8 Months | Current |
Financials of Kopran Research Laboratories Limited FY 2024 filings available
Kopran Research Laboratories Limited reported revenue of ₹365.89 Cr (up 13.00% YoY) for FY 2025.
Ten-year financial statements for Kopran Research Laboratories Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kopran Research Laboratories Limited
Shareholding and ownership data for Kopran Research Laboratories Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kopran Research Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2020 | State Bank of India | ₹69.25 Cr | Open |
| 09 May 2016 | Sbicap Trustee Company Limited | ₹124.75 Cr | Open |
| 04 May 2023 | Others | ₹28 Cr | Satisfied |
| 16 Mar 2021 | Yes Bank Limited | ₹11.5 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Kopran Research Laboratories Limited
Kopran Research Laboratories Limited has a workforce of 538 employees as of Apr 10, 2025.
Employee and EPFO history for Kopran Research Laboratories Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Kopran Research Laboratories Limited
GST registrations and filing compliance for Kopran Research Laboratories Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Kopran Research Laboratories Limited
Credit ratings, litigation, and regulatory alerts for Kopran Research Laboratories Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kopran Research Laboratories Limited
MSME payment history for Kopran Research Laboratories Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kopran Research Laboratories Limited
Corporate group structure for Kopran Research Laboratories Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kopran Research Laboratories Limited
MCA filings and documents for Kopran Research Laboratories Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Kopran Research Laboratories Limited
Recent News on Kopran Research Laboratories Limited
Frequently Asked Questions about Kopran Research Laboratories Limited
Kopran Research Laboratories Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 12 August 1986 (40+ years old) and is registered under CIN U24230MH1986PLC040601. The company has 538 employees.
Kopran Research Laboratories Limited reported revenue of ₹365.89 Cr for FY 2025 (up 13.00% YoY).
The current directors of Kopran Research Laboratories Limited are:
- Sunita Banerji - Director
- Rakesh Arunkumar Doshi - Director
- Chandra Mohan Singhi - Whole-Time Director
- Vandana Surendra Somani - Director
- Mamta Ashok Biyani - Director
The primary industry of Kopran Research Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Kopran Research Laboratories Limited can be reached at the registered office: 1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, India – 400018, or through the website kopran.com.
The authorised capital is ₹25 Cr, and the paid-up capital is ₹22.5 Cr.